Lifting the fog in intermediate-risk (submassive) PE: full dose, low dose, or no thrombolysis? [version 1; peer review: 2 approved]

by Amyn Bhamani, Joanna Pepke-Zaba, Karen Sheares
Published 2019-03-01

Maximal cardiac output determines 6 minutes walking distance in pulmonary hypertension.

by Gaël Deboeck, Dolores Taboada, Guy Hagan, Carmen Treacy, Kathy Page, Karen Sheares, Robert Naeije, Joanna Pepke-Zaba
Published 2014-01-01

Balloon pulmonary angioplasty for inoperable chronic thromboembolic pulmonary hypertension: the UK experience

by Karen Sheares, Stephen P Hoole, John E Cannon, Dolores Taboada, Mark Toshner, Andrew John Fletcher, Guillermo Martinez, Alessandro Ruggiero, Nicholas Screaton, Joanna Pepke-Zaba
Published 2020-06-01

Correction: Selective and marked decrease of complement receptor C5aR2 in human thoracic aortic aneurysms: a dysregulation with potential inflammatory effects

by Karen Sheares, Stephen P Hoole, John E Cannon, Dolores Taboada, Mark Toshner, Andrew John Fletcher, Guillermo Martinez, Alessandro Ruggiero, Nicholas Screaton, Joanna Pepke-Zaba
Published 2020-06-01

Correction: New score for assessing bleeding risk in patients with atrial fibrillation treated with NOACs

by Karen Sheares, Stephen P Hoole, John E Cannon, Dolores Taboada, Mark Toshner, Andrew John Fletcher, Guillermo Martinez, Alessandro Ruggiero, Nicholas Screaton, Joanna Pepke-Zaba
Published 2020-06-01

A minimal clinically important difference measured by the Cambridge Pulmonary Hypertension Outcome Review for patients with idiopathic pulmonary arterial hypertension

by Katherine Bunclark, Natalie Doughty, Alice Michael, Nisha Abraham, Samantha Ali, John E Cannon, Karen Sheares, Nicola Speed, Dolores Taboada, Mark Toshner, Joanna Pepke-Zaba
Published 2021-05-01